Disease Markers

Disease Markers / 2008 / Article
Special Issue

Stem Cells and Disease

View this Special Issue

Open Access

Volume 24 |Article ID 905025 | https://doi.org/10.1155/2008/905025

Yunhui Zhang, Renshan Ge, Matthew P. Hardy, "Androgen-Forming Stem Leydig cells: Identification, Function and Therapeutic Potential", Disease Markers, vol. 24, Article ID 905025, 10 pages, 2008. https://doi.org/10.1155/2008/905025

Androgen-Forming Stem Leydig cells: Identification, Function and Therapeutic Potential

Received21 May 2008
Accepted21 May 2008

Abstract

Leydig cells are the primary source of testosterone in the male, and differentiation of Leydig cells in the testes is one of the primary events in the development of the male body and fertility. Stem Leydig cells (SLCs) exist in the testis throughout postnatal life, but a lack of cell surface markers previously hindered attempts to obtain purified SLC fractions. Once isolated, the properties of SLCs provide interesting clues for the ontogeny of these cells within the embryo. Moreover, the clinical potential of SLCs might be used to reverse age-related declines in testosterone levels in aging men, and stimulate reproductive function in hypogonadal males. This review focuses on the source, identification and outlook for therapeutic applications of SLCs. Separate pools of SLCs may give rise to fetal and adult generations of Leydig cell, which may account for their observed functional differences. These differences should in turn be taken into account when assessing the consequences of environmental pollutants such as the phthalate ester, diethylhexylphthalate (DEHP).

Copyright © 2008 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Order printed copiesOrder
Views569
Downloads493
Citations

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.